Inertia or inaction? blood pressure management and cardiovascular risk in diabetes

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 7, 2009, Pages 643-647

  Owen, Aj ^a   Retegan, C ^b   Rockell, M ^b   Jennings, G ^b   Reid, Cm ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cardiovascular risk; Diabetes; Prevention; Primary care

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUSTRALIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIET THERAPY; FEMALE; GENERAL PRACTITIONER; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; RISK FACTOR; THERAPY EFFECT;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 67650735730     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05125.x     Document Type: Article

References (27)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 : 1047 53.
2. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: Meta-analysis of 37 prospective cohort studies. BMJ 2006 332 : 73 8.
3. Howard BV, Best LG, Galloway JM et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006 29 : 391 7.
4. Jacobs MJ, Kleisli T, Pio JR et al. Prevalence and control of dyslipidemia among persons with diabetes in the United States. Diabetes Res. Clin. Pract. 2005 70 : 263 9.
5. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am. J. Med. 2006 119 : 133 41.
6. Hypertension in Diabetes Study (HDS) I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J. Hypertens. 1993 11 : 309 17.
7. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: An update. Hypertension 2001 37 : 1053 9.
8. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998 317 : 703 13.
9. Patel A, ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type-2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet 2007 370 : 829 40.
10. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 2006 47 : 345 51.
11. Grundy SM, Garber A, Goldberg R et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV. Lifestyle and medical management of risk factors. Circulation 2002 105 : E153 8.
12. National Heart Foundation of Australia. Hypertension Management Guide 2004. National Heart Foundation, Melbourne. 2003.
13. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 2003 21 : 1983 92.
14. Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database Syst. Rev. 2005 2 : CD005270.
15. Orchard TJ, Temprosa M, Goldberg R et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program randomized trial. Ann. Intern. Med. 2005 142 : 611 19.
16. Dunstan DW, Salmon J, Owen N et al. Physical activity and television viewing in relation to risk of undiagnosed abnormal glucose metabolism in adults. Diabetes Care 2004 27 : 2603 9.
17. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005 28 : 514 20.
18. Duggirala MK, Cuddihy RM, Cuddihy MT, Nyman MA, Naessens JM, Pankratz VS. Women with diabetes have poorer control of blood pressure than men. J. Womens Health 2005 14 : 418 23.
19. International Diabetes Federation. Global Guideline for Type 2 Diabetes. International Diabetes Federation, Brussels. 2005.
20. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann. Intern. Med. 1992 117 : 234 42.
21. Lee YJ, Chiang YF, Tsai JC. Severe nonproductive cough and cough-induced stress urinary incontinence in diabetic postmenopausal women treated with ACE inhibitor. Diabetes Care 2000 23 : 427 8.
22. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994 308 : 81 106.
23. American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care 2004 27 (Suppl. 1 S72 3.
24. Rodondi N, Vittinghoff E, Cornuz J et al. Aspirin use for the primary prevention of coronary heart disease in older adults. Am. J. Med. 2005 118 : 1288.
25. Mehta SS, Silver RJ, Aaronson A, Abrahamson M, Goldfine AB. Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus. Am. J. Cardiol. 2006 97 : 567 70.
26. Charles J, Ng A, Miller G. Management of type 2 diabetes in Australian general practice. Aust. Fam. Physician 2006 35 : 378 9.
27. Roncaglioni MC, Avanzini F, Roccatagliata D, Monesi L et al. How general practitioners perceive and grade the cardiovascular risk of their patients. Eur. J. Cardiovasc. Prev. Rehabil. 2004 11 : 233 8.